Literature DB >> 5952734

Quinacrine effects on the central nervous system.

G L Engel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5952734

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease.

Authors:  Michael D Geschwind; Amy L Kuo; Katherine S Wong; Aissa Haman; Gillian Devereux; Benjamin J Raudabaugh; David Y Johnson; Charles C Torres-Chae; Ron Finley; Paul Garcia; Julie N Thai; Hugo Q Cheng; John M Neuhaus; Sven A Forner; Jacque L Duncan; Katherine L Possin; Stephen J Dearmond; Stanley B Prusiner; Bruce L Miller
Journal:  Neurology       Date:  2013-10-11       Impact factor: 9.910

2.  Clinical trials for prion disease: difficult challenges, but hope for the future.

Authors:  Michael D Geschwind
Journal:  Lancet Neurol       Date:  2009-03-09       Impact factor: 44.182

3.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.